Impact of Pseudoexfoliative Syndrome on Effective Lens Position, Anterior Chamber Depth Changes, and Visual Outcome After Cataract Surgery

Figures & data

Table 1 Baseline Demographics in the Two Study Groups, with and without Pseudoexfoliation Syndrome (PEX)

Parameters	PEX (n=28 Eyes)	Control (n=28 Eyes)	p-value
Age [years]	75 ± 6.2 (63–86)	71 ± 8.0 (53–88)	0.074
Gender (female/male)	18 (64%)/10 (36%)	16 (57%)/12 (43%)	0.584
Glaucoma	10 (36%)	1 (4%)	0.002
PNS	1.4 (1–3)	1.4 (0–3)	0.860
ACD [mm]	2.54 ± 0.42	2.53 ± 0.38	0.941
DCVA [logMAR]	0.45 ± 0.30	0.40 ± 0.29	0.469
Kmax [D]	43.62 ± 1.18	43.80 ± 1.82	0.812
AL [mm]	23.55 ± 1.47	23.29 ± 1.32	0.334
Lens power (D)	21.22 ± 3.89	21.50 ± 3.22	0.786
Lens thickness [mm]	4.77 ± 0.44	4.81 ± 0.43	0.643

Abbreviations: ACD, anterior chamber depth; AL, axial length; DCVA, distance corrected visual acuity; Kmax, maximal keratometry; PNS, Pentacam Nucleus Staging.

Table 2 Anterior Chamber Depth (ACD) and Distance Corrected Visual Acuity (DCVA) Three Months After Cataract Surgery in Patients with and without Pseudoexfoliation Syndrome (PEX)

3 Months Postoperative	PEX (n=28 Eyes)	Control (n=28 Eyes)	p-value
ACD	4.29 ± 0.71	4.33 ± 0.72	0.533
Delta ACD	1.75 ± 0.74	1.81 ± 0.61	0.806
DCVA	0.11 ± 0.13	0.09 ± 0.17	0.245
Delta DCVA	0.38 ± 0.34	0.30 ± 0.27	0.414

Abbreviations: ACD, anterior chamber depth; DCVA, distance corrected visual acuity.

Table 3 Correlation Between 3 Months Postoperative Anterior Chamber Depth (ACD), Delta ACD, Distance Corrected Visual Acuity (DCVA) and Delta DCVA in Patients with and without Pseudoexfoliation Syndrome (PEX)

3 Months Postoperative	ACD	Delta ACD	DCVA	Delta DCVA
PEX patients
ACD	1.00	0.89*	−0.45*	−0.33
delta ACD	0.89*	1.00	−0.31	−0.34
DCVA	−0.45*	−0.31	1.00	0.16
delta DCVA	−0.33	−0.34	0.16	1.00
Normal patients
ACD	1.00	0.80*	−0.08	0.20
delta ACD	0.80*	1.00	−0.12	0.22
DCVA	−0.08	−0.12	1.00	−0.11
delta DCVA	0.20	0.22	−0.11	1.00

Note: *Significant correlation p<0.05.

Abbreviations: ACD, anterior chamber depth; DCVA, distance corrected visual acuity.

Figure 1 Comparison of the preoperative and postoperative anterior chamber depth (ACD) in patients with and without pseudoexfoliation syndrome (PEX).

Figure 2 Comparison of the preoperative and postoperative anterior chamber depth (ACD) in patients with and without pseudoexfoliation syndrome (PEX) in relation to the axial length.

Figure 3 Comparison of the anterior chamber depth (ACD) difference in patients with and without pseudoexfoliation syndrome (PEX) in relation to C Factor.